Assistance Publique des Hôpitaux de Paris SA
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1849-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.aphp.fr
Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Arrhythmia or Tachycardia
Phase 3
Active, not recruiting
- Conditions
- Patent Foramen OvaleAtrial ArrhythmiaCryptogenic Stroke
- Interventions
- First Posted Date
- 2022-01-28
- Last Posted Date
- 2024-04-05
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 186
- Registration Number
- NCT05213104
- Locations
- 🇫🇷
Hopital Pitié Salpetrière, Paris, IDF, France
Impact of Closely Grouped, Iterative Exposures to Suxamethonium During ECT on the Sensitization to NMBA and the Development of Protective Antibodies
- Conditions
- ManiaDepressionHallucinations
- Interventions
- Other: Iterative exposure to suxamethonium during ECT sessions
- First Posted Date
- 2022-01-27
- Last Posted Date
- 2022-04-12
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 70
- Registration Number
- NCT05210062
- Locations
- 🇫🇷
Saint-Antoine Hospital, Paris, France
Rituximab in Patients with ST-elevation Myocardial Infarction
Phase 2
Recruiting
- Conditions
- ST Elevated Myocardial Infarction
- Interventions
- Drug: Placebo armDrug: Active arm 200 mgDrug: Active arm 1000 mg
- First Posted Date
- 2022-01-27
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 558
- Registration Number
- NCT05211401
- Locations
- 🇫🇷
Cardiology department, Hôpital Bichat, AP-HP, Paris, France
Sexual Needs of Adolescents Living With HIV Since Childhood
Completed
- Conditions
- HivPerinatal HIV Infection
- Interventions
- Other: Interview
- First Posted Date
- 2022-01-25
- Last Posted Date
- 2023-07-10
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 27
- Registration Number
- NCT05206123
- Locations
- 🇫🇷
Maison de Solenn, Paris, France
Impact of Computerized Decision Support for ANTIBIOtic Prescription in Cancer Patients With Febrile NEutropenia in the Emergency Department on Treatment Failure.
Not Applicable
- Conditions
- Febrile Neutropenia
- Interventions
- Other: Computerized Decision support app (CDSA)Other: routine care
- First Posted Date
- 2022-01-25
- Last Posted Date
- 2022-01-25
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 540
- Registration Number
- NCT05206006
TOtal Skin Electron Beam Therapy (Low-dose) for Tumor Clone Eradication in Early-stage Mycosis Fungoides
Phase 3
Not yet recruiting
- Conditions
- Mycosis FungoidesCutaneous T Cell Lymphoma
- Interventions
- Other: Low-dose total-skin electron-beam therapyOther: Phototherapy
- First Posted Date
- 2022-01-25
- Last Posted Date
- 2022-01-25
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 78
- Registration Number
- NCT05205902
Trial of Auricular Vagus Nerve Stimulation in Painful Covid Long
Not Applicable
Recruiting
- Conditions
- COVID-19
- First Posted Date
- 2022-01-25
- Last Posted Date
- 2024-02-22
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 30
- Registration Number
- NCT05205577
- Locations
- 🇫🇷
Service Centre d'Evaluation et de Traitement de la Douleur, Paris, France
Evolution of the SURvival of Patients With SEzary Syndrome (SS) Over the 1998-2020 Period and Its Association With the Early Use of Therapeutic Monoclonal Antibodies
- Conditions
- Sezary SyndromeCutaneous T Lymphoma
- Interventions
- Other: Standard of care
- First Posted Date
- 2022-01-25
- Last Posted Date
- 2022-01-25
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 700
- Registration Number
- NCT05206045
- Locations
- 🇫🇷
Hôpital Saint-Louis, Service de Dermatologie, Paris, France
Prospective Evaluation of the Prognostic Impact of Measurable Residual Disease (MRD) Within a Phase III Study Comparing a Fixed Duration Therapy Versus Continuous Therapy With Daratumumab, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma Requiring a First Salvage Treatment.
Recruiting
- Conditions
- Multiple Myeloma
- Interventions
- Other: Assessment of MRD
- First Posted Date
- 2022-01-24
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 260
- Registration Number
- NCT05203003
- Locations
- 🇫🇷
Department of Hematology, Hospital Saint Antoine, Paris, France
Screening for 3-D Visual Disorders in Preschool Children
Not Applicable
Completed
- Conditions
- AmblyopiaAnisometropiaStrabismus
- Interventions
- First Posted Date
- 2022-01-24
- Last Posted Date
- 2022-01-24
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 95
- Registration Number
- NCT05204069
- Locations
- 🇫🇷
Robert Debre Hospital, Paris, France
© Copyright 2025. All Rights Reserved by MedPath